Craig Johnson

Track

Insider profile

Currently holds positions in Novadel Pharma Inc, Mirati Therapeutics Inc, La Jolla Pharmaceutical Co, Heron Therapeutics Inc and Odonate Therapeutics Inc

Positions

Position Company Period
Chief Financial Officer, Senior Vice President, Secretary Novadel Pharma Inc June 16, 2010 -
Independent Director Mirati Therapeutics Inc Aug. 30, 2013 -
Independent Director La Jolla Pharmaceutical Co Oct. 14, 2013 -
Independent Director Heron Therapeutics Inc Jan. 10, 2014 -
Independent Director Odonate Therapeutics Inc July 1, 2017 -
Independent Director Adamis Pharmaceuticals Corp Feb. 10, 2011 - Aug. 25, 2014
Independent Director Ardea Biosciences Inc July 1, 2008 - June 19, 2012
Chief Financial Officer PURE Biosciences Inc Aug. 1, 2011 - May 4, 2012
Craig Johnson's trades of Heron Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-12-23 2021-12-21
PlS Planned sale
84,859 -5.5%
354.35
US$2,917,387 		84,859 -5.5% 354.35 US$2,917,387
2021-06-22 2021-06-21
PlS Planned sale
97,111 +42.3%
95.38
US$4,745,950 		97,111 +42.3% 95.38 US$4,745,950
2021-04-07 2021-04-06
PlS Planned sale
80,478 -35.4%
498.90
US$4,047,304 		80,478 -35.4% 498.90 US$4,047,304
2021-01-25 2021-01-21
PlS Planned sale
334 -8.8%
214.75
US$71,728 		334 -8.8% 214.75 US$71,728
2021-01-25 2021-01-21
PlS Planned sale
44 -1.1%
213.62
US$9,399 		44 -1.1% 213.62 US$9,399
2021-01-25 2021-01-21
PlS Planned sale
3,372 -46.7%
212.97
US$718,151 		3,372 -46.7% 212.97 US$718,151
2021-01-25 2021-01-21
PlS Planned sale
4,562 -38.7%
211.94
US$966,852 		4,562 -38.7% 211.94 US$966,852
2021-01-25 2021-01-21
PlS Planned sale
3,183 -21.3%
210.81
US$671,004 		3,183 -21.3% 210.81 US$671,004
2021-01-25 2021-01-21
PlS Planned sale
3,505 -19.0%
210.01
US$736,070 		3,505 -19.0% 210.01 US$736,070
2020-04-21 2020-04-20
PlS Planned sale
15,000 -88.2%
93.00
US$1,395,000 		15,000 -88.2% 93.00 US$1,395,000
2019-01-31 2019-01-29
PlS Planned sale
8,525 -100.0%
61.80
US$526,831 		8,525 -100.0% 61.80 US$526,831
2019-01-31 2019-01-29
PlS Planned sale
8,475 -49.9%
61.11
US$517,941 		8,475 -49.9% 61.11 US$517,941